Teleflex Incorporated (TFX) Insider Thomas E. Powell Sells 5,200 Shares of Stock

Teleflex Incorporated (NYSE:TFX) insider Thomas E. Powell sold 5,200 shares of Teleflex stock in a transaction on Friday, October 12th. The shares were sold at an average price of $246.84, for a total value of $1,283,568.00. Following the completion of the sale, the insider now owns 15,351 shares in the company, valued at approximately $3,789,240.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

TFX stock opened at $249.13 on Tuesday. The company has a current ratio of 2.21, a quick ratio of 1.45 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $12.19 billion, a P/E ratio of 29.66, a PEG ratio of 1.87 and a beta of 1.12. Teleflex Incorporated has a 12-month low of $227.52 and a 12-month high of $288.78.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 2nd. The medical technology company reported $2.47 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.41 by $0.06. The firm had revenue of $609.87 million for the quarter, compared to the consensus estimate of $615.97 million. Teleflex had a return on equity of 17.32% and a net margin of 3.78%. The company’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.04 EPS. On average, research analysts expect that Teleflex Incorporated will post 9.82 EPS for the current year.

Several hedge funds have recently bought and sold shares of the stock. Scout Investments Inc. raised its holdings in shares of Teleflex by 106.9% in the 3rd quarter. Scout Investments Inc. now owns 132,023 shares of the medical technology company’s stock valued at $35,130,000 after buying an additional 68,198 shares during the period. Lourd Capital LLC purchased a new stake in Teleflex during the 3rd quarter worth about $310,000. United Services Automobile Association increased its holdings in Teleflex by 13.3% during the 2nd quarter. United Services Automobile Association now owns 32,040 shares of the medical technology company’s stock worth $8,593,000 after purchasing an additional 3,764 shares during the period. Royal London Asset Management Ltd. purchased a new stake in Teleflex during the 2nd quarter worth about $5,107,000. Finally, Bank of New York Mellon Corp increased its holdings in Teleflex by 0.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 548,319 shares of the medical technology company’s stock worth $147,064,000 after purchasing an additional 1,783 shares during the period. Hedge funds and other institutional investors own 88.89% of the company’s stock.

TFX has been the topic of a number of research analyst reports. ValuEngine downgraded Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, August 3rd. Needham & Company LLC reduced their target price on Teleflex from $298.00 to $279.00 and set a “buy” rating on the stock in a research report on Friday, August 3rd. Morgan Stanley reduced their target price on Teleflex from $310.00 to $295.00 and set an “overweight” rating on the stock in a research report on Friday, August 3rd. TheStreet downgraded Teleflex from a “b” rating to a “c+” rating in a research report on Friday, August 3rd. Finally, Barclays assumed coverage on Teleflex in a research report on Monday. They issued an “equal weight” rating on the stock. Three analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the stock. Teleflex presently has a consensus rating of “Buy” and a consensus target price of $289.25.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Recommended Story: Diversification in Your Portfolio

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply